Literature DB >> 12382970

Polyethylene and methyl methacrylate particle-stimulated inflammatory tissue and macrophages up-regulate bone resorption in a murine neonatal calvaria in vitro organ system.

Weiping Ren1, Bin Wu, Lois Mayton, Paul H Wooley.   

Abstract

There is considerable evidence that orthopaedic wear debris plays a crucial role in the pathology of aseptic loosening of joint prostheses. This study examined the effect of inflammatory membranes stimulated with methyl methacrylate and polyethylene on bone resorption, using the murine air pouch model. The capacity of RAW 264.7 mouse macrophages exposed to polymer particles to produce factors affecting bone metabolism was also studied. Neonatal calvaria bones were co-cultured with either pouch membranes or conditioned media from activated macrophages. Bone resorption was measured by the release of calcium from cultured bones, and the activity of tartrate-resistant acid phosphatase in both bone sections and culture medium was also assayed. Results showed that inflammatory pouch membrane activated by methyl methacrylate and polyethylene enhanced osteoclastic bone resorption. Conditioned media from particles stimulated mouse macrophages also stimulated bone resorption, although this effect was weaker than resorption induced by inflammatory pouch membranes. The addition of the particles directly into the medium of cultured calvaria bones had little effect on bone resorption. Our observations indicate that both inflammatory tissue and macrophages provoked by particles can stimulate bone resorption in cultured mouse neonatal calvaria bones. This simple in vitro bone resorption system allows us to investigate the fundamental cellular and molecular mechanism of wear debris induced bone resorption and to screen potential therapeutic approaches for aseptic loosening.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382970     DOI: 10.1016/S0736-0266(02)00019-0

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  7 in total

1.  Continuous infusion of UHMWPE particles induces increased bone macrophages and osteolysis.

Authors:  Pei-Gen Ren; Afraaz Irani; Zhinong Huang; Ting Ma; Sandip Biswal; Stuart B Goodman
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

2.  Selective inhibition of the MCP-1-CCR2 ligand-receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particles.

Authors:  Emmanuel Gibon; Ting Ma; Pei-Gen Ren; Kate Fritton; Sandip Biswal; Zhenyu Yao; Lane Smith; Stuart B Goodman
Journal:  J Orthop Res       Date:  2011-09-12       Impact factor: 3.494

3.  An in vivo murine model of continuous intramedullary infusion of polyethylene particles.

Authors:  Ting Ma; Zhinong Huang; Pei-Gen Ren; Ryan McCally; Derek Lindsey; R L Smith; Stuart B Goodman
Journal:  Biomaterials       Date:  2008-06-18       Impact factor: 12.479

4.  Inhibitory effects of erythromycin on wear debris-induced VEGF/Flt-1 gene production and osteolysis.

Authors:  David C Markel; Renwen Zhang; Tong Shi; Monica Hawkins; Weiping Ren
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

5.  In vivo murine model of continuous intramedullary infusion of particles--a preliminary study.

Authors:  Ting Ma; Steven G Ortiz; Zhinong Huang; Peigen Ren; R Lane Smith; Stuart B Goodman
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2009-01       Impact factor: 3.368

6.  Effects of SU5416 and a vascular endothelial growth factor neutralizing antibody on wear debris-induced inflammatory osteolysis in a mouse model.

Authors:  Weiping Ren; Renwen Zhang; Bin Wu; Paul H Wooley; Monica Hawkins; David C Markel
Journal:  J Inflamm Res       Date:  2011-03-02

7.  Therapeutic potentials of naringin on polymethylmethacrylate induced osteoclastogenesis and osteolysis, in vitro and in vivo assessments.

Authors:  Nianhu Li; Zhanwang Xu; Paul H Wooley; Jianxin Zhang; Shang-You Yang
Journal:  Drug Des Devel Ther       Date:  2013-12-10       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.